REFRACTORY SEPTIC SHOCK DEFINED BY VIS SCORE: CHARACTERISTICS AND ASSOCIATION WITH CLINICAL OUTCOMES
Main Article Content
Abstract
Introduction: The Vasoactive-Inotropic Score (VIS) has not been investigated as a potential alternative to norepinephrine dose thresholds in defining refractory septic shock. Objective: To examine the clinical characteristics and outcomes of patients with refractory septic shock defined by the VIS score. Methods: A prospective observational study was conducted on 151 patients with septic shock admitted to the Intensive Care Unit of Hoan My Cuu Long Hospital from January 2023 to December 2024. Results: The prevalence of refractory septic shock defined by a VIS score >50 was 31.1%. Baseline clinical and laboratory characteristics were similar between groups. However, the rates of renal replacement therapy (48.9% vs. 13.5%), mechanical ventilation (83.0% vs. 29.8%), and 30-day mortality (72.3% vs. 26.9%) were significantly higher in the refractory shock group (p < 0.001). In multivariable Cox regression analysis, refractory septic shock was associated with an increased risk of 30-day mortality (HR = 3.19; 95% CI: 1.82–5.59), and a higher VIS score was also associated with increased mortality risk (HR = 1.01; 95% CI: 1.00–1.01). Conclusion: Patients with refractory septic shock defined by a VIS score >50 had more severe illness and worse clinical outcomes compared to those without refractory shock. The VIS score was independently associated with an increased risk of 30-day mortality in patients with septic shock.
Article Details
Keywords
Vasoactive-Inotropic Score (VIS), septic shock, refractory shock
References
2. Kwak, G.H., R. Madushani, L. Adhikari, A.Y. Yan, E.S. Rosenthal, K. Sebbane, et al., Septic Shock Requiring Three Vasopressors: Patient Demographics and Outcomes. Crit Care Explor, 2024. 6(11):e1167.
3. Ro, S.K., W.K. Kim, J.Y. Lim, J.S. Yoo, S.B. Hong, and J.B. Kim, Extracorporeal life support for adults with refractory septic shock. J Thorac Cardiovasc Surg, 2018. 156(3):1104-1109.e1.
4. Nandhabalan, P., N. Ioannou, C. Meadows, and D. Wyncoll, Refractory septic shock: our pragmatic approach. Crit Care, 2018. 22(1):215.
5. Evans, L., A. Rhodes, W. Alhazzani, M. Antonelli, C.M. Coopersmith, C. French, et al., Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med, 2021. 47(11):1181-1247.
6. Song, J., H. Cho, D.W. Park, S. Moon, J.Y. Kim, S. Ahn, et al., Vasoactive-Inotropic Score as an Early Predictor of Mortality in Adult Patients with Sepsis. J Clin Med, 2021. 10(3).
7. Li, W., Y. Wang, B. Abuduaini, X. Li, P. Pan, J. Cui, et al., Prognostic evaluation of the norepinephrine equivalent score and the vasoactive-inotropic score in patients with sepsis and septic shock: a retrospective cohort study. Front Cardiovasc Med, 2024. 11:1415769.
8. Singer, M., C.S. Deutschman, C.W. Seymour, M. Shankar-Hari, D. Annane, M. Bauer, et al., The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). Jama, 2016. 315(8):801-10.
9. Gattinoni, L., F. Vasques, L. Camporota, J. Meessen, F. Romitti, I. Pasticci, et al., Understanding Lactatemia in Human Sepsis. Potential Impact for Early Management. Am J Respir Crit Care Med, 2019. 200(5):582-589.
10. Mongardon, N., Q. de Roux, M. Leone, and P. Guerci, Norepinephrine formulation for equivalent vasopressive score. Crit Care, 2023. 27(1):62.